Turkish Journal of Pharmaceutical Sciences最新文献

{"title":"Dexamethasone and Citicoline Mitigate Cisplatin-Induced Peripheral Neuropathy: A Novel Experimental Study in Mice.","authors":"Farid Masoud,&nbsp;Bohloul Habib-Asl,&nbsp;Mohammad Charkhpour,&nbsp;Yashar Asadpour,&nbsp;Javad Mahmudi","doi":"10.4274/tjps.galenos.2021.51882","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.51882","url":null,"abstract":"<p><strong>Objectives: </strong>Given the rising prevalence of cisplatin-induced peripheral neuropathy (CisIPN), investigations to alleviate its adverse effects are required. Oxidative stress and free radical development are essential pathways of CisIPN. Specifically, dexamethasone and citicoline are characterized by anti-inflammatory and antioxidant activities that might reduce CisIPN incidence and severity. The current study assessed the possible impacts of novel interventions, dexamethasone, and, citicoline on CisIPN.</p><p><strong>Materials and methods: </strong>Seventy-two male mice were randomly allocated into nine groups (n: 8/each group). Different doses of dexamethasone (7.5, 15, 30 mg/kg, <i>i.p.</i>), citicoline (10, 20, 40 mg/kg, <i>i.p.</i>), and the combination (dexamethasone 7.5 mg/kg + citicoline 10 mg/kg, <i>i.p.</i>) were injected in the first three days and one day before receiving cisplatin (2 mg/kg, <i>i.p.</i>). The tail-flick method was used for assessing nociception. Besides, malondialdehyde (MDA), interleukin-1 beta (IL-1β), tumor necrosis factor-α (TNF-α), total antioxidant capacity (TAC), and mice weight differences (ΔW) were measured.</p><p><strong>Results: </strong>Different doses of dexamethasone and citicoline enhanced latency time (<i>p</i><0.05). Moreover, dexamethasone 15 mg/kg diminished the level of MDA and increased TAC (<i>p</i><0.05) and in 30 mg/kg, MDA was reduced (<i>p</i><0.05). Besides, 20 and 40 mg/kg of citicoline reduced MDA and elevated TAC (<i>p</i><0.05), and 10 mg/kg merely reduced MDA (<i>p</i><0.05). Dexamethasone in all doses declined IL-1β and TNF-α levels, and citicoline only at 40 mg/kg lessened their levels (<i>p</i><0.05). Interestingly, ΔW declined more in the dexamethasone and citicoline groups than the cisplatin group (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>Dexamethasone and citicoline attenuate CisIPN through anti-inflammatory activity, improving the antioxidant capacity, and inhibiting lipid peroxidation.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"505-512"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634451/pdf/TJPS-19-505.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40660460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nasotransmucosal Delivery of Curcumin-Loaded Mucoadhesive Microemulsions for Treating Inflammation-Related CNS Disorders.","authors":"Mukeshkumar Shamalbhai Patel,&nbsp;Snigdha Das Mandal,&nbsp;Surjyanarayan Mandal,&nbsp;Shital Faldu,&nbsp;Jayvadan Patel","doi":"10.4274/tjps.galenos.2021.45945","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.45945","url":null,"abstract":"<p><strong>Objectives: </strong>This investigation was aimed at designing an effective mucoadhesive microemulsion system to accomplish higher brain uptake of curcumin through intranasal route.</p><p><strong>Materials and methods: </strong>Mucoadhesive microemulsion of curcumin (MMEC) was developed using screened oil, surfactant, and co-surfactant by Box-Behnken design and was evaluated for mucoadhesion, stability, and naso-ciliotoxicity study. Comparative brain uptake of curcumin after nasal administration of MMEC and polycarbophil curcumin gel and intravenous administration of plain curcumin solution was studied by performing bio-distribution study in Swiss albino rats.</p><p><strong>Results: </strong>The results showed that all formulation variables i.e., the amount of capmul MCM (X1), S_mix (accenon CC: transcutol P) (X2) and percentage of aqueous. Polycarbophil (X3) had a significant effect (p<0.05) on the responses. The developed MMEC was stable and non-ciliotoxic with 66.74 ± 3.46 nm and 98.58% ± 1.21 as average globule size and drug content, respectively. Polydispersibility index (0.133 ± 0.17) data and transmission electron microscopy study depicted the narrow size distribution of MMEC. Furthermore, following a comparative investigation of the brain uptake of curcumin among MMEC, plain drug gel and intravenous administration at 2.86 mg/kg, more brain uptake of curcumin was demonstrated for MMEC over intravenous application. Moreover, curcumin uptake in olfactory bulb after nasal administration of MMEC (31.11 ± 1.6) was than 9.44 times higher than intravenous injection of curcumin solution (3.25 ± 1.01). Area under curve represents the ratio of 2.86 mg/kg in brain tissue to plasma acquired afterward(s) the intranasal injection of MMEC (and it) was essentially greater than after the intravenous administration of curcumin solution.</p><p><strong>Conclusion: </strong>Findings of the investigation revealed that optimal MMEC and intranasal route may be considered to be promising and an alternative approach for brain targeting of curcumin.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"560-571"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634447/pdf/TJPS-19-560.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40674380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fabrication and Evaluation of Matrix Type Novel Transdermal Patch Loaded with Tramadol Hydrochloride.","authors":"Shankhadip Nandi,&nbsp;Saptarshi Mondal","doi":"10.4274/tjps.galenos.2021.43678","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.43678","url":null,"abstract":"<p><strong>Objectives: </strong>Transdermal drug delivery as a novel drug delivery system has become a major research interest to the scientists for its controlled drug release and improved patient compliance. This study was conducted to develop an optimized transdermal patch of tramadol hydrochloride using an appropriate amount of suitable polymers. It was also planned to control the drug permeation rate from the device to achieve a sustained release pattern.</p><p><strong>Materials and methods: </strong>Several numbers of formulations were prepared by altering the amount of excipients. Physicochemical and biopharmaceutical parameters were checked to get the optimized formulation with desired characteristics.</p><p><strong>Results: </strong>Fourier transform infrared spectroscopy results displayed no abnormal peaks and hence concluded that the drug and polymers were compatible with each other. The minimum standard deviation values of different physicochemical parameters assured that the method of preparation was skilled to develop patches with least intra-batch variability. A higher percentage of hydroxypropyl methylcellulose (HPMC) resulted in the greater tensile strength, moisture content and water vapor transmission rate of the patches. A high folding endurance value (>200) indicated the flexibility of the prepared patches and their integrity to the skin. The transdermal patches coded as F26 containing only HPMC polymer demonstrated the desired drug permeation rate (65.51%) within 12 hours through <i>ex vivo</i> permeation studies.</p><p><strong>Conclusion: </strong>The formulation coded as F26 was found to be the most optimized patch as it exhibited sustained drug permeation rate followed by higuchi diffusion kinetics, that also confirmed the capability of the formulation to exhibit matrix type drug delivery.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"572-582"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634439/pdf/TJPS-19-572.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analgesic and Sedative-Hypnotic Potentiality of Crude Methanolic Extract of <i>Gomphandra tetrandra</i> (Wall.) Sleumer Leaves.","authors":"N M Mahmudul Alam Bhuiya,&nbsp;Forman Hossen,&nbsp;Monirul Islam,&nbsp;Moynul Hasan","doi":"10.4274/tjps.galenos.2021.09216","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.09216","url":null,"abstract":"<p><strong>Objectives: </strong><i>Gomphandra tetrandra</i> (Wall.) Sleumer (leaves) belonging to the family Stemonuraceae was investigated for preliminary phytochemical screening and evaluating their pharmacological activities in various pharmacological models.</p><p><strong>Materials and methods: </strong>The crude methanolic extract was screened with different chemical reagents for the qualitative detection of different phytochemical groups. The peripheral analgesic function was determined using the acetic acid-induced writhing procedure and sedative-hypnotic behaviors were assessed using hole-board, open field, and hole-cross tests using different doses of the extract (200 mg/kg and 400 mg/kg body weight).</p><p><strong>Results: </strong>Phytochemical screening revealed that methanolic extract of <i>G. tetranda</i> leaves contains steroids, gums, mucilages, phytosterols, carbohydrates, and flavonoids. The crude methanolic extract at 200 mg/kg and 400 mg/kg doses showed statistically significant activity in acetic acid-induced writhing inhibition test with 60% (<i>p</i><0.01) and 76.47% (<i>p</i><0.01) inhibition, respectively, compared to control. The extract also had dose-dependent substantial (<i>p</i><0.01) sedative-hypnotic activities compared with diazepam in the hole-board, open field, and hole-cross tests.</p><p><strong>Conclusion: </strong>It may be assumed that the methanolic leaf extract of <i>G. tetrandra</i> possesses a strong possibility of having analgesic and sedative-hypnotic activity due to the presence of bioactive compounds in its leaves. Moreover, observed results have opened a new era of in-depth research to discover the possible mechanism of analgesic and sedative-hypnotic activity.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"583-588"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634441/pdf/TJPS-19-583.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determination of Metoclopramide Hydrochloride in Pharmaceutical Formulations using <i>N</i>-Oxidation Caroate.","authors":"Mykola Blazheyevskiy,&nbsp;Deghinmotei Alfred-Ugbenbo,&nbsp;Olena Oleksandrivna Mozgova,&nbsp;Valery Petrovich Moroz","doi":"10.4274/tjps.galenos.2021.33733","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.33733","url":null,"abstract":"<p><strong>Objectives: </strong>To develop two (titrimetric and spectrophotometric) simple, rapid, sensitive and cost-effective methods for the determination of metoclopramide (MCP) in pharmaceutical dosage forms.</p><p><strong>Materials and methods: </strong>The titrimetric method (A) was based on the <i>N</i>-oxidation reaction involving the use of potassium hydrogen peroxymonosulfate and subsequent iodometric back titration of a known residual reagent. The spectrophotometric method (B) was based on derivatization of MCP with potassium hydrogen peroxymonosulfate in the presence of iodide to produce a chromogen (triiodide) with a wavelength of maximum absorption at 350 nm.</p><p><strong>Results: </strong>Method \"A\" was applicable over the concentration range of 0.25-3.5 mg to end volume 10 mL. In method \"B\", Beer's law was obeyed over the concentration range of 0.3-3.5 μg/mL with molar absorptivity of 24600 L/mol cm. The limits of quantification were calculated to be 0.25 mg/10 mL (A) and 0.2 μg/mL (B), respectively.</p><p><strong>Conclusion: </strong>The proposed methods were suitable for determination of MCP as a pure substance in tablets and injection.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"589-594"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634443/pdf/TJPS-19-589.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation of Selected Medicinal Plants for Their Anti-Obesity Properties.","authors":"Sıla Özlem Şener,&nbsp;Eylül Cılız,&nbsp;Berre Nur Öztekin,&nbsp;Merve Badem,&nbsp;Ufuk Özgen","doi":"10.4274/tjps.galenos.2021.97572","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.97572","url":null,"abstract":"<p><strong>Objectives: </strong>Obesity, which is a risk factor for diabetes, hypertension, cardiovascular diseases, and cancer, is caused serious health problems and economic costs on a global scale. Nowadays, pancreatic lipase inhibitors that cause inhibition of lipid digestion and lipid absorption are one of the limited treatment approaches for obesity. Plant-derived secondary metabolites can be used for treating obesity. The aim of this study was to research the antiobesity potential of <i>Amaranthus albus</i> L. (Amaranthaceae), <i>Helichrysum compactum</i> Boiss. (Asteraceae), <i>Chenopodium album</i> L. (Chenopodiaceae), and <i>Agrimonia eupatoria</i> L. (Rosaceae).</p><p><strong>Materials and methods: </strong>To detect the antiobesity potentials of the plants, <i>in vitro</i> lipase inhibitory activity studies by spectroscopic method and quantitative analysis studies of some anti-obesity effective secondary metabolites by reversed-phase high performance liquid chromatography (RP-HPLC) technique were carried out.</p><p><strong>Results: </strong><i>In vitro</i> lipase inhibitory studies showed that all plant extracts possess lipase inhibitory effect, and the highest lipase inhibitory potential was observed for <i>H. compactum</i> (IC₅₀: 45.70 μg/mL ± 2.3618). According to HPLC analyses, <i>p</i>-coumaric acid (0.27 mg/g) in <i>A. albus</i>; benzoic acid (0.33 mg/g) in <i>C. album</i>; vanillic acid (7.32 mg/g), syringaldehyde (14.97 mg/g), quercetin (4.66 mg/g), <i>p</i>-coumaric acid (0.71 mg/g), and benzoic acid (3.43 mg/g) in <i>H. compactum</i>; <i>p</i>-coumaric acid (0.71 mg/g) and benzoic acid (3.43 mg/g) in <i>A. eupatoria</i> were detected.</p><p><strong>Conclusion: </strong>In conclusion, <i>H. compactum</i> is the most remarkable natural source for the study. The fact remains that all plants may be promising candidates for treating obesity.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"498-504"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634444/pdf/TJPS-19-498.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and Evaluation of Floating Microspheres of Anticonvulsant Drug by 3² Full Factorial Design.","authors":"Manish Bhise,&nbsp;Karunakar Shukla,&nbsp;Sourabh Jain,&nbsp;Nitin Bhajipale,&nbsp;Suresh Sudke,&nbsp;Pramod Burakle","doi":"10.4274/tjps.galenos.2021.53050","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.53050","url":null,"abstract":"<p><strong>Objectives: </strong>Present study was to develop and evaluate gastroretentive microspheres by the solvent evaporation technique.</p><p><strong>Materials and methods: </strong>Gabapentin and HPMC K100 were used to develop the formulations. Gastroretentive microspheres were developed by the solvent evaporation technique from the preliminary batches of gabapentin microspheres batch FMG3 were selected for factorial study.</p><p><strong>Results: </strong>Factorial batches showed the mean particle size of the floating microsphere formulations for gabapentin (FFMG1-FFMG9) was in the range of 185.63 ± 0.13 to 510.04 ± 0.09 μm. The percentage yields of formulations FFMG1 to FFMG9 for gabapentin ranged from 53.5 ± 0.95 to 96.64 ± 0.42. The buoyancy percentage was calculated for the formulations and found that all formulations could float on dissolution medium for 12 h. The drug loading in gabapentin microspheres was found 65.29 ± 0.46 to 84.3 ± 0.44. The swelling study was found to be 756.34 ± 1.48 to 890.46 ± 0.78 for gabapentin. Batch FFMG6 and FFMC2 showed better drug release 99.1% and 99.25% respectively. The optimized formulation FFMG6 for gabapentin showed an n value 0.8474 and R² value 0.9965.</p><p><strong>Conclusion: </strong>Optimized formulation obeys Korsmeyer-Peppas release. Scanning electron microscopy images of microspheres were spherical, discrete, and freely flowing. ANOVA for the given formulations showed <i>p</i> value less than 0.0500. The stability study indicated no significant changes in the microspheres. In radiographic images, floating microspheres were retained in the stomach of rabbits for twelve hours.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"595-602"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634442/pdf/TJPS-19-595.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety in Cosmetics and Cosmetovigilance, Current Regulations in Türkiye.","authors":"İmran Altıokka,&nbsp;Melike Üner","doi":"10.4274/tjps.galenos.2021.40697","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.40697","url":null,"abstract":"<p><p>Although it is considered that cosmetics do not have side effects, studies have revealed that a significant number of consumers experience side effects. Undesirable effects arising from the use of cosmetic products have created the need for a reporting and evaluation system, which is responsible for some restrictions on the use of cosmetics ingredients and putting into cosmetic regulation effect, called cosmetovigilance. However, the new cosmetovigilance concept needs some updates to become more effective for public health. For instance, side effects related to cosmetic use have been reported more frequently recently, but this rate is still quite low. Additionally, since the current cosmetic directive does not recognize cosmeceuticals as a distinct category from cosmetics, some products named cosmetic under the laws may affect the bottom layers of dermis and cause systemic side effects. Although the manufacturers must show safety assessments to the Turkish Pharmaceutical and Medical Device Agency to get a license, after launching they do not have post-vigilance reporting to the institution, which is another problem of the system. In this review, the current cosmetovigilance system in Türkiye was discussed and some hardships encountered were criticized regarding the implementation of the system. Additionally, scientific studies are conducted on cosmetic ingredients that can have side effects and contribute to the developing cosmetovigilance concept. Because of the study, the importance of the feedback of healthcare professionals in the cosmetovigilance system, the consultancy service to be given to the consumer and patient about the contents that should be considered. Besides, there is a need for new studies to indicate the adverse reaction incidence related to cosmetics in the Turkish market. Another outcome of this review article is to understand the importance of the new regulations regarding the increase in the new active ingredients in the cosmetic market.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"610-617"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634450/pdf/TJPS-19-610.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stability Indicating RP-HPLC and Spectrophotometric Methods for Simultaneous Estimation of Sodium Benzoate and Cefdinir in the Presence of its Degradation Products-Application to Blank Subtraction Method.","authors":"Mahmoud Abdelfettah Mohamed,&nbsp;Mohamed El-Kassem Mohamed Hassouna","doi":"10.4274/tjps.galenos.2021.35020","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.35020","url":null,"abstract":"<p><strong>Objectives: </strong>Empower 3 software is important in modeling, optimization, and reducing the time of manual calculation of related substance by subtracting the baseline of a blank chromatogram from the unknown sample automatically; so, the major objective of the developed method is to introduce a new, selective, and economical high performance liquid chromatography (HPLC) and spectrophotometric method for simultaneous estimation of sodium benzoate (SDB) and cefdinir (CFR) in the presence of its degradation products.</p><p><strong>Materials and methods: </strong>Chromatographic separation is optimized and adjusted using two methods; method (I) is characterized for separation of active pharmaceutical ingredient (CFR) in pure and dosage forms using Atlantis dC18 column [4.6 mm x 250 mm (5 μm particle size or equivalent)] with a mobile phase consisting of methanol: 0.02 M phosphate buffer solution pH 3.0 (40:60 v/v) at a flow rate of 1.0 mL/minute, injection volume 10 μL and wavelength 254 nm. Method (II) is identified for related substances in a Hichrom C18 column (15 x 0.46 cm), 5 μm particle size or equivalent, using a binary gradient consisting of solution A [0.1% tetramethylammonium hydroxide solution (pH: 5.5) with 0.1 M EDTA (1000:0.4 v/v)] and solution B (0.1% tetramethylammonium hydroxide solution (pH 5.5): acetonitrile: methanol : 0.1 M EDTA (500:300:200:0.4 v/v) using injection volume 10 μL for reversed-phase HPLC with a wavelength equals to 254 nm and flow rate 1.0 mL/min. Two ecofriendly spectrophotometric methods were successfully used to resolve the spectral overlap of drugs.</p><p><strong>Results: </strong>Method A, the first derivative of ratio spectra spectrophotometric method (1stDD) where CFR was determined at two wavelengths 283.5 nm, 313.4 nm and SDB was determined at 216.7 nm, 235.5 nm. Method B, ratio subtraction method is performed to overcome the interference between CFR and the preservative SDB. The ultraviolet spectrum of the laboratory mixture is divided by that of CFR (20 μg/mL) as a divisor then subtracting the amplitudes in the plateau region at 250-315 nm (the constant) from that of the ratio spectrum. The zero-order spectra of SDB were obtained at 225 nm by multiplying the resulting ratio spectra by the divisor (CFR), zero order of CFR was been estimated at a wavelength value of 283 nm after multiplication of the divisor by the obtained constant.</p><p><strong>Conclusion: </strong>The optimized method was adjusted and validated as <i>per</i> International Conference on Harmonization guidelines and could be easily utilized by quality control laboratories and for laboratory-prepared mixtures.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"530-542"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634448/pdf/TJPS-19-530.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Potential Drug Interactions in Adults Living in Manaus: A Real-World Comparison of Two Databases, 2019.","authors":"Tayanny Margarida Menezes Almeida Biase,&nbsp;Giulia Sartori Bruniéri,&nbsp;Marcus Tolentino Silva,&nbsp;Taís Freire Galvão","doi":"10.4274/tjps.galenos.2021.96603","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.96603","url":null,"abstract":"<p><strong>Objectives: </strong>Drug information systems are commonly used by professionals to assist in the identification of drug interactions and to ensure the safe use of medications. Real-world evidence about the comparison of different drug interaction sources is scarce. We aimed to compare two drug interaction databases to identify interactions in a population-based survey.</p><p><strong>Materials and methods: </strong>This is a cross-sectional study based on a previous survey performed in the city of Manaus, Brazil, in 2019. We included adults aged 18 years and over, who used two or more medicines 15 days before the interview. To assess potential drug interactions, we searched Micromedex and UpToDate databases. The primary outcome was the prevalence of potential drug interactions in each database. Weighted Kappa statistics were calculated to assess agreement on the presence of drug interaction, documentation and severity.</p><p><strong>Results: </strong>A total of 752 participants were included in the study. The prevalence of drug interactions was 43.8% [95% confidence interval (CI): 40.2, 47.3%] in UpToDate and 30.2% (95% CI: 26.9, 33.5%), in Micromedex. The agreement related to drug interactions between the two databases was fair (Kappa: 0.631). For severity (Kappa: 0.398) and documentation (Kappa: 0.311), the agreement was poor.</p><p><strong>Conclusion: </strong>Agreement among compared databases was sub-optimal. Better quality and transparency of evidence available in drug interaction sources are needed to support informed healthcare professionals' decision.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"543-551"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634440/pdf/TJPS-19-543.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}